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Gene Inactivation by CRISPR-Cas9 in
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Cells
Sébastien Mercx, Jérémie Tollet, Bertrand Magy, Catherine Navarre and Marc Boutry*
Institut des Sciences de la Vie, Université Catholique de Louvain, Louvain-la-Neuve, Belgium
Plant suspension cells are interesting hosts for the heterologous production of
pharmacological proteins such as antibodies. They have the advantage to facilitate
the containment and the application of good manufacturing practices. Furthermore,
antibodies can be secreted to the extracellular medium, which makes the purification
steps much simpler. However, improvements are still to be made regarding the
quality and the production yield. For instance, the inactivation of proteases and the
humanization of glycosylation are both important targets which require either gene
silencing or gene inactivation. To this purpose, CRISPR-Cas9 is a very promising
technique which has been used recently in a series of plant species, but not yet in
plant suspension cells. Here, we sought to use the CRISPR-Cas9 system for gene
inactivation in Nicotiana tabacum BY-2 suspension cells. We transformed a transgenic
line expressing a red fluorescent protein (mCherry) with a binary vector containing genes
coding for Cas9 and three guide RNAs targeting mCherry restriction sites, as well as
a bialaphos-resistant (bar) gene for selection. To demonstrate gene inactivation in the
transgenic lines, themCherry gene was PCR-amplified and analyzed by electrophoresis.
Seven out of 20 transformants displayed a shortened fragment, indicating that a deletion
occurred between two target sites. We also analyzed the transformants by restriction
fragment length polymorphism and observed that the three targeted restriction sites
were hit. DNA sequencing of the PCR fragments confirmed either deletion between two
target sites or single nucleotide deletion. We therefore conclude that CRISPR-Cas9 can
be used in N. tabacum BY2 cells.
Keywords: CRISPR, Cas9, plants, suspension cells, gene inactivation, gene targeting
INTRODUCTION
Nicotiana tabacum cv. Bright yellow 2 (BY-2) suspension cells have been used as a model in a
wide range of cellular and physiological studies such as the cell cycle regulation or the eﬀects
of environmental conditions and stresses on the plant physiology (Koukalova et al., 1989; Shaul
et al., 1996; Fiserova et al., 2006). Moreover BY-2 cells have been shown to be able to produce
recombinant proteins, and thus represent an alternative host in the molecular farming ﬁeld (De
Muynck et al., 2010; Schillberg et al., 2013). Typically, cell cultures are grown in contained
bioreactors and thus have the advantage of animal and microbial cultures regarding the process
control. Recombinant proteins, such as antibodies, can be secreted to the extracellular medium
allowing for a puriﬁcation step much simpler than if they were retained into the cell. The
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downstream processing costs are thus lower compared to
the whole plant system. However, improvements still have
to be made regarding the quality and the production rate.
For instance, the humanization of glycosylation is required
for glycosylated proteins used in therapy. Inactivation of
extracellular proteases might be crucial to avoid degradation
of recombinant proteins. The possibility of modifying the
expression of genes is also an important tool for more basic
projects, e.g., aimed at deciphering molecular aspects of a plant
cell. These applied or basic targets can be best achieved by
genetic engineering tools resulting in either gene silencing or
gene inactivation.
Gene silencing by RNA interference has been largely used in
plants as well as in plant cells. This approach suﬀers from the
fact that gene silencing is rarely complete and might not be stable
over time. From this point of view, gene inactivation by mutation
or deletion is more eﬀective but, except for the collections of
knock-out lines in Arabidopsis, has rarely been implemented in
plants because there was no simple method available. Recently,
the CRISPR (clustered regularly interspaced short palindromic
repeat)/Cas9 (CRISPR-associated) system has been successfully
used in a wide range of plant species (Bortesi and Fischer, 2015)
but not in plant suspension cells. The system is based on a short
RNA guide (sgRNA) which associates to the Cas9 endonuclease
to create a double-stranded break (DSB) in the target genomic
DNA. As a consequence, mutations are generated through either
error-prone non-homologous end-joining (NHEJ) or homology-
directed repair (HDR) of the intended cleavage site. NHEJ
has been used to generate mutagenic insertions/deletions often
leading to gene inactivation. In this report, we tested the
CRISPR/Cas9 system in N. tabacum BY-2 cells. As a proof of
concept we demonstrate the feasibility of using this system to
inactivate a reporter gene (mCherry) that had been introduced
in the genome.
MATERIALS AND METHODS
Plant Cell Cultures
Nicotiana tabacum cv. BY-2 (Nagata et al., 1992) suspension
cells were grown in the dark at 25◦C with agitation on a rotary
shaker (90 rpm) in liquid MS medium [4.4 g/L Murashige and
Skoog salts (MP BIOMEDICALS, Solon, OH), 30 g/L sucrose,
0.2 g/L KH2PO4, 2.5 mg/L thiamine, 50 mg/ml myo-inositol, and
0.2 mg/L 2,4-D, pH 5.8 (KOH)].
Cultures were grown in 50 mL of medium in a 250-
mL Erlenmeyer ﬂask and a 5% inoculum was transferred
each week into fresh medium. Transformed cells were
grown on solid medium supplemented with 20 µg/mL of
bialaphos.
Generation of the SC6 Transgenic Line
A cDNA coding for the monomeric ﬂuorescent protein mCherry
gene (Shaner et al., 2004) controlled by the double-enhanced
cauliﬂower mosaic virus 35S promoter was inserted in the
pPZP-RCS2-nptII-HIgG2-LoBM2 vector (Magy et al., 2014)
which contains an expression cassette for the monoclonal
antibody Lo-BM2 (Figure 1). The binary vector was transferred
into Agrobacterium tumefaciens LBA4404virG (van der Fits
et al., 2000) by electroporation. A. tumefaciens was cultured
for 16 h in 50 ml of culture medium supplemented with
antibiotics (20 µg/ml rifampicin, 40 µg/ml gentamicin, 50 µg/ml
kanamycin) as well as 100 µM acetosyringone. After harvesting
by centrifugation at 3,500 g, the bacteria were resuspended at
an O.D. of 1 (600 nm) in MS medium supplemented with
100 µM acetosyringone and 10 mM MgSO4. The suspension
was incubated for 3 h at room temperature with shaking and
then 40 ml were mixed with 4 ml of a 6 days old BY-2 cell
culture and poured onto solid MS medium containing 100 µM
acetosyringone. After 2 days at 25◦C, the cells were washed
and cultured in liquid MS medium for 3 days and plated
on solid MS media supplemented with 500 µg/ml cefotaxim,
400 µg/ml carbenicillin, 100 µg/ml kanamycin. A line displaying
mCherry ﬂuorescence (SC6) was chosen as a target for further
work.
Cas9 and sgRNA Plasmid Construction
and Plant Cell Transformation
pFGC-pcoCas9 was a gift from Jen Sheen (Addgene plasmid #
52256). The three sgRNAs were constructed by overlapping PCR,
inserted into the pGEM-T-easy vector (Promega), sequenced,
and then introduced into either the AscI (sgRNA1), PacI
(sgRNA2), or SbfI (sgRNA3) cloning sites of the pFGC-pcoCas9
binary vector (Li et al., 2013). The vector was transferred into
A. tumefaciens LBA4404virG (van der Fits et al., 2000) by
electroporation. Transformation of N. tabacum BY-2 cells was
performed as indicated above except that the selection was on
20 µg/ml bialaphos.
RNA Extraction and RT-PCR
BY-2 cells (100 mg) were collected 3 days after co-cultivation with
A. tumefaciens, frozen in liquid nitrogen, and ground in powder.
Then, RNA was extracted with the SpectrumTM Plant Total
RNA Kit (Sigma–Aldrich). cDNA was synthesized by mixing
0.2µg RNA, 10 µMoligo dT, 10 µMoligo gRNA-mCherry-RT-R
(hybridizing to sgRNAs), and H2O up to 15 µl. After incubation
for 5 min at 70◦C, the sample were placed on ice and 5 µl 5x
M-MLV buﬀer (Promega), 1.25 µl dNTPs (10 mM), 25 U RNase
inhibitor, 200 UM-MLVRT (Promega), and 16.75 µl H20 were
added. The sample was incubated for 1 h at 42◦C. PCR was
performed according to the GoTaq R© DNA Polymerase protocol
(Promega).
Analysis of Genome Modification
Genomic DNA was extracted from stable transgenic
transformants from the bialaphos selection and SC6 non-
transformed cells. PCR was performed using primers
ﬂanking mCherry (Table 1) and the ampliﬁed fragments
were electrophoresed on an ethidium bromide-stained agarose
gel (2%). For the restriction fragment length polymorphism
(RFLP) analysis, the PCR product was digested with the
corresponding enzymes chosen for each target site and
electrophoresed on an ethidium bromide-stained agarose gel
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FIGURE 1 | mCherry binary vector used for transformation of Nicotiana tabacum BY-2 cells mediated by Agrobacterium tumefaciens. T-DNA left and
right borders are indicated by LB and RB, respectively; nptII, neomycin phosphotransferase II expression cassette; P35S, double-enhanced cauliflower mosaic virus
35S promoter; mCherry, coding sequence for the monomeric fluorescent protein mCherry; En2pPMA4, N. plumbaginifolia promoter (NpPMA4) reinforced by two
copies of the CaMV 35S enhancer; HC, heavy chain; LC, light chain; T, nopaline synthase polyadenylation sequence (tNOS); aaDa, resistance gene to the
aminoglycosides spectinomycin and streptomycin.
TABLE 1 | Primers used in this study.
Primer name Sequence (5′ to 3′ ) Usage
U6-AscI-F
gRNA-mCherry1-R
gRNA-mCherry1-F
gRNA-AscI-R
CGAGGCGCGCCAGAAATCTCAAAATTCCG
TGTGCACCTTGAAGCGCATGCAATCACTACTTCGTCTCT
GCATGCGCTTCAAGGTGCACAGTTTTAGAGCTAGAAATAGC
CGAGGCGCGCCTAATGCCAACTTTGTACA
For creating
sgRNA1
U6-PacI-F
gRNA-mCherry2-R
gRNA-mCherry2-F
gRNA-PacI-R
CGATTAATTAAAGAAATCTCAAAATTCCG
GGGACATCCTGTCCCCTCAGCAATCACTACTTCGTCTCT
GCTGAGGGGACAGGATGTCCCGTTTTAGAGCTAGAAATAGC
CGATTAATTAATAATGCCAACTTTGTACA
For creating
sgRNA2
U6-SbfI-F
gRNA-mCherry3-R
gRNA-mCherry3-F
gRNA-SbfI-R
CGACCTGCAGGAGAAATCTCAAAATTCCG
ACGTGAAGCACCCCGCCGACAATCACTACTTCGTCTCT
GTCGGCGGGGTGCTTCACGTGTTTTAGAGCTAGAAATAGC
CGACCTGCAGGTAATGCCAACTTTGTACA
For creating
sgRNA3
Cas9RT-F
Cas9RT-R
gRNA-mCherry1RT-F
gRNA-mCherry2RT-F
gRNA-mCherry3RT-F
gRNA-mCherryRT-R
CTACGTTGGACCACTTGC
ACAGAATCGAAGCACTCG
CTTCAAGGTGCACAGTTTT
GACAGGATGTCCCGTTTT
GGGTGCTTCACGTGTTT
ACTCGGTGCCACTTTTTC
RT-PCR
mCherry-F
mCherry Rev1
AAGGGCGAGGAGGATAAC
CAGCCTCTGCTTGATCTC
PCR
(2%). For further characterization the bands were puriﬁed and
sequenced.
RESULTS
Design of the CRISPR/Cas9 System
Targeting mCherry in Nicotiana tabacum
BY-2 Cells
To test the potential of CRISPR/Cas9 to generate a gene
knockout in N. tabacum BY-2 cells we obtained a transgenic
line (SC6) containing a reporter gene expressing the mCherry
ﬂuorescent protein. This line was obtained after transformation
of BY-2 cells with a vector previously used to express an
antibody (Magy et al., 2014) in which we inserted the mCherry
gene (Figure 1). A transgenic line, SC6, was chosen for its
high mCherry expression. Three regions of mCherry were
targeted by three sgRNAs (Figure 2A). We selected the target
sites for the presence of a restriction site to facilitate the
identiﬁcation of mutations by an RFLP assay. We expected
short INDELs at diﬀerent target sites but also deletions between
two target sites if a break occurs at two sites simultaneously
(Figure 2B).We constructed the pFGC-Cas9-sgRNA1-2-3 binary
vector containing an Arabidopsis codon-optimized version of
Cas9 controlled by the 35S-PPDK promoter, a bar gene for
selection, and three sgRNAs (controlled by the U6 promoter)
targeting mCherry (Figure 2C). The sgRNAs of each target
site were generated by overlapping PCR and cloned into the
pFGC-Cas9 vector. The SC6 cell line was transformed with
A. tumefaciens carrying pFGC-Cas9-sgRNA1-2-3. Three days
after transformation, we sought to determine whether the genes
for Cas9 and the sgRNAs were expressed. At that stage, no
selection had been applied and transient expression was checked
in the whole cell suspension by RT-PCR analysis. Transcripts for
both cas9 and sgRNA were identiﬁed (Figure 2D). Afterward,
the cell suspension was spread on a selection medium containing
bialaphos to isolate transformed calli.
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FIGURE 2 | Genome editing in Nicotiana tabacum BY-2 cells using a transgenic line expressing a fluorescent protein mCherry (SC6) by
CRISPR/Cas9. (A) Schematic representation of the mCherry gene and the three target sites. Three regions of mCherry were selected for the presence of a
restriction site (ApaLI, BsaAI, and AhdI) to facilitate the mutation analysis by RFLP. Primers F and R were used to amplify mCherry in order to examine the mutations.
The distance between the three target sites and the mCherry translation start is indicated. P35S: CaMV 35S transcription promoter. NOS, nopaline synthase
terminator. The sequence corresponding to the sgRNA is displayed below in colors. The PAM sequences are in red. (B) Schematic representation of the expected
mutation types. INDELs can be created by a single break. Breaks occurring at two sites simultaneously result in a deletion between those sites. (C) Schematic
representation of the pFGC-Cas9-sgRNA1-2-3 vector used in this study. Cas9 is controlled by the 35S-PPDK transcription promoter and three sgRNAs were
integrated in the vector downstream of the U6 transcription promoter. A bar gene permits the selection of transformants. (D) Expression analysis by RT-PCR of Cas9
and the sgRNAs 3 days post-transformation with A. tumefaciens carrying the pFGC-Cas9-sgRNA1-2-3 vector. As a control, WT BY-2 cells were transformed with a
vector (pPZP-mCherry) expressing mCherry.
CRISPR/Cas9 Induces INDELs and
Fragment Deletion in mCherry
Random transformants were transferred twice on a fresh
bialaphos selection medium and then checked for the
ﬂuorescence of mCherry. Loss of ﬂuorescence was observed in
19 out of 21 transformants. This loss was partial (chimeras) for
15 lines and complete for the other four (Figures 3A,B). To
conﬁrm that the loss of ﬂuorescence was due to mutations in
mCherry, genomic DNA extraction was performed followed by
PCR ampliﬁcation of the target region (Figure 3C). Seven out
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FIGURE 3 | Continued
Frontiers in Plant Science | www.frontiersin.org 5 February 2016 | Volume 7 | Article 40
Mercx et al. Gene Inactivation in Nicotiana tabacum Cells
FIGURE 3 | Continued
Analysis of genome editing at themCherry locus. Cells of the SC6 line
were transformed with pFGC-Cas9-sgRNA1-2-3 targeting mCherry.
Transformants appeared after 3 weeks on bialaphos selection medium and
were transferred twice on new selection medium. (A) Picture of the calli under
visible light (left) and fluorescence of mCherry (right). (B) Close-up of four calli:
lines 15 (homogenous mCherry fluorescence), 18 (no mCherry fluorescence) 6
and 20 (heterogenous mCherry fluorescence). (C) Genome editing in
transformed calli was monitored by PCR amplification of mCherry. Deletion
between two target sites occurred in seven out of 20 transformants (lines 1, 2,
8, 9, 17, 18, 19). pPZP: amplification of mCherry directly from the plasmid
pPZP-mCherry. (D) Genotyping of nine transformants by RFLP analysis. The
PCR fragments from lines 1 to 9 displayed in (C) were subjected to digestion
by the indicated restriction enzymes.
of 20 lines tested showed, in addition to the undeleted fragment,
shortened fragments, which correspond to deletions between
two target sites. To determine whether INDELs occurred within
the full size fragments, RFLP analysis was performed directly on
the PCR products of the ﬁrst nine clones (Figure 3D). Three
out of nine lines exhibited a band partially resistant to ApaLI
digestion, indicating the creation of short INDELs in target 1.
Five out of the nine lines were mutated in target 2, and ﬁve in
target 3. CRISPR-Cas9 together with the three sgRNAs thus
created mutations in all the lines except for line 15, in which
a loss of ﬂuorescence was not observed. However, the lines
were not homogenous for the mutations. Instead, for most of
them, a mix of INDELs at two or three targets was identiﬁed.
To further characterize mutations, four PCR fragments (three
with a shorter size and one with a full size) were cloned and
sequenced (Figure 4). The full size fragment displayed a single
base deletion in target 3. One shortened fragment resulted from
a deletion between targets 2 and 3, and the last two fragments,
from a deletion between targets 1 and 3.
DISCUSSION
In the present study, we showed that CRISPR/Cas9 can be used
as a powerful tool for engineering the N. tabacum BY-2 genome.
Previous studies showed the possibility to induce mutations in
the genome of various plants or plant protoplasts (Jiang et al.,
2013; Li et al., 2013; Gao et al., 2015), but plant suspension cells
had not yet been used as a target.
Since the eﬃciency of the CRISPR/Cas9 in N. tabacum BY-
2 cells was unknown, we targeted the marker gene mCherry,
the expression of which could be monitored by ﬂuorescence.
However, selection of non-ﬂuorescent transformants was not
necessary as among the 21 transformants randomly chosen, four
had lost their mCherry ﬂuorescence. However, 15 chimeric calli
were also observed. This indicates that Cas9 had not yet provoked
any genomic break in some of the cells. An explanation is that
the initial transformant was actually a mix of two transformation
events, one of which did not lead to the expression of Cas9
and/or sgRNAs, either because of incomplete transfer of the
T-DNA, or because of a position eﬀect. Another explanation is
that after transformation, a ﬁrst target site was hit after the ﬁrst
cell division, resulting in a chimeric callus.
On the whole, RFLP analysis indicated that all three mCherry
targets were hit. In addition, the deletion of a fragment between
two targets was also observed, which shows that in some cases,
Cas9 had hit two targets before non-homologous end-joining
reparation had occurred at each site. This observation suggests
that homology-directed repair might be feasible in suspension
cells. When examining individual transformants, heterogeneity
was usually observed, with a mix of hits at one, two, or three
targets. However, no case was found where the three sites were
homogenously mutated, and only one case out of nine was found
where a single site was homogenously mutated (line 6 at target
3). As hypothesized before, this suggests that after transformation
FIGURE 4 | Sequence of the edited sites. PCR fragments amplified from the mCherry genes were cloned and sequenced. The sequence of four clones is
displayed below the sequence of the non-edited mCherry. The sgRNA and the PAM positions are indicated.
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with A. tumefaciens cell division of the transformed cells usually
occurred before a target was mutated by Cas9. In this case,
mutations appear over time when the callus grows, resulting
in chimeric clones. However, homogenous mutant lines can be
obtained by subcloning. When too diluted, plant suspension
cells do not grow, thus preventing isolated colonies from being
obtained. However, an alternative consists of mixing transformed
cells with an excess of feeding wild-type cells and selecting
isolated calli on a selection medium (Kirchhoﬀ et al., 2012).
CONCLUSION
Targeting three sites of a gene of interest, we showed that it is
possible to use CRISPR/Cas9 to knock-out this gene. Besides
single mutations at one of the targets, double breaks and deletion
of the intervening sequence were also observed, opening the way
to homologous recombination by homology-directed repair.
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